BABITA JOHN

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health FRISCO, TX NPI 1902492945

General Payments — all program years on this page

$1,518.20

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 71
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $460.59 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $460.5921

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $204.717
2022 $332.5015
2023 $520.4028
2024 $460.5921

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100329060 Novo Nordisk Inc $21.65 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105552518 AstraZeneca Pharmaceuticals LP $13.61 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105757489 AstraZeneca Pharmaceuticals LP $18.78 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114720146 Exact Sciences Corporation $14.95 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114720152 Exact Sciences Corporation $20.10 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115767837 Amgen Inc. $23.27 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116760836 Renalytix AI, Inc. $23.29 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117589475 Amgen Inc. $22.23 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118227842 Boehringer Ingelheim Pharmaceuticals, Inc. $15.72 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118227846 Boehringer Ingelheim Pharmaceuticals, Inc. $17.61 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118227850 Boehringer Ingelheim Pharmaceuticals, Inc. $21.02 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125627734 Seqirus USA Inc $21.94 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135540397 Lilly USA, LLC $16.97 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135552273 Lilly USA, LLC $13.39 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135562506 Lilly USA, LLC $16.34 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135573820 Lilly USA, LLC $20.08 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135573822 Lilly USA, LLC $18.41 04/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144711832 Cleerly, Inc. $55.19 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144711842 Cleerly, Inc. $47.40 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148970035 Sumitomo Pharma America, Inc. $19.59 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153350922 Dexcom, Inc. $19.05 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.